Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN6 SHORT NOTE 5M ★ High-yield

Describe central serous chorioretinopathy and macular hole.

Ophthalmology · 3rd Professional

Central Serous Chorioretinopathy

Central serous chorioretinopathy (CSCR) is a localised serous detachment of the neurosensory retina at the macula, caused by leakage through a defective retinal pigment epithelium over a thickened, hyperpermeable choroid.

  • The classical patient is a young or middle-aged male, often with a driven, "type A" personality, under stress
  • The single most important association IS corticosteroid exposure, by any route — oral, inhaled, nasal, topical skin creams, intra-articular and intravenous. It must be asked about explicitly, because patients do not regard creams and inhalers as drugs, and stopping the steroid is often the whole treatment
  • Other associations — endogenous hypercortisolism (Cushing syndrome); pregnancy, in which it resolves after delivery; sympathomimetics; obstructive sleep apnoea; Helicobacter pylori; and psychological stress

Macular Hole and Epiretinal Membrane

  • A full-thickness macular hole is a defect of the neurosensory retina at the fovea, caused by anteroposterior and tangential vitreomacular traction as the vitreous separates
  • an idiopathic condition of women in the sixth and seventh decades; also follows trauma and high myopia
  • Symptoms — gradual central blurring, metamorphopsia and a central scotoma; acuity falls to around 6/60
  • GASS staging — stage 1, impending hole with a foveal cyst and loss of the foveal depression; stage 2, a small full-thickness hole; stage 3, a full hole over 400 micrometres with the vitreous still attached; stage 4, a full hole with complete posterior vitreous detachment
  • The WATZKE-ALLEN test — a narrow slit beam across the fovea appears broken or thinned to the patient in a full-thickness hole, and merely distorted in a pseudohole. OCT is now diagnostic and has replaced clinical staging
  • Differential — a lamellar hole (partial thickness); a pseudohole in an epiretinal membrane, in which the retina is intact but the membrane creates the appearance of a hole; and vitreomacular traction
  • Treatment — pars plana vitrectomy with internal limiting membrane peeling and gas tamponade, with face-down posturing afterwards. Closure rates exceed 90%, and the outcome depends on the duration and size of the hole, so referral should not be delayed. Ocriplasmin is an enzymatic alternative for selected small holes with traction
  • Epiretinal membrane (macular pucker, cellophane maculopathy) — a fibrocellular sheet on the internal limiting membrane which contracts and wrinkles the retina. idiopathic in most, following posterior vitreous detachment; or secondary to retinal tear or detachment surgery, vein occlusion, uveitis, diabetes or trauma

All questions in The Retina and Vitreous

  1. Q1Describe the anatomy and physiology of the retina and the vitreous. ★
  2. Q2Describe diabetic retinopathy with its classification and management. ★
  3. Q3Describe the retinal vascular occlusions with their management. ★
  4. Q4Describe retinal detachment with its types, features and management. ★
  5. Q5Describe age-related macular degeneration with its management. ★
  6. SN1Describe retinitis pigmentosa with its features and associations. ★
  7. SN2Describe retinopathy of prematurity with its screening and treatment. ★
  8. SN3Describe hypertensive retinopathy and the other systemic retinopathies. ★
  9. SN4Describe posterior vitreous detachment, vitreous haemorrhage and vitreous opacities. ★
  10. SN5Describe retinoblastoma with its genetics, presentation and management. ★
  11. SN6Describe central serous chorioretinopathy and macular hole. ★
  12. SN7Describe the investigations used in retinal disease.

Every Ophthalmology chapter →

Scroll to Top